We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Europital, a global provider of medical management services for clinical research and drug development, is opening a UK site to further expand its services to the UK biotech industry.
The new R&D facility will add to Biocon’s 200,000-square-foot R&D site in Bengaluru. In all, Biocon has 28 molecules in development, including 11 under a partnership with Mylan, a few others with Novartis' Sandoz and the remainder independently.
The site now has a new Product Development & QC Lab area with 13 processing suites, two new packaging suites, serialization, and new manufacturing suites.